AP
Alseres Pharmaceuticals Inc /DE Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by GIPSON ROBERT L, was filed 23 Apr 2009.
Alseres Pharmaceuticals Inc /DE: what insiders have been doing
This page follows insider dealings at Alseres Pharmaceuticals Inc /DE as filed with SEC (Form 4). Alseres Pharmaceuticals Inc /DE has had no insider filing for more than a year; the last one goes back to 27 December 2011.
Looking back to 2007, when coverage begins, insiders filed 2 purchases and no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€2M
2 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2013FY ended December 2013 · cache
Income statement
Revenue422k
Net income-838.7k-198.7% margin
Last declaration on 27 December 2011
Declarations15 total
- 2,331,034 shares0common stockSEC:0001041885-11-000098:0
- 537,931 shares0common stockSEC:0001041885-11-000097:0
- 537,931 shares@ US$2.50COMMON STOCKSEC:0001041885-11-000090:0
- 2,331,034 shares@ US$2.50common stockSEC:0001041885-11-000091:0
- 60,000 shares@ US$0.01COMMON STOCKSEC:0001041885-11-000084:0
- 530,000 shares@ US$0.01Common StockSEC:0001041885-11-000085:0
- 4,600,000 shares0COMMON STOCKSEC:0001041885-11-000083:0
- 270,000 shares@ US$0.03COMMON STOCKSEC:0001041885-11-000008:0
- 543,478 shares@ US$1.84Common StockSEC:0001041885-09-000080:0Canonical exit: 18 Feb 2009 (T+90)
- 1,456,522 shares@ US$0.687Common StockSEC:0001041885-09-000080:1Canonical exit: 9 Apr 2009 (T+90)
- 4,485 shares0Common StockSEC:0001209191-08-000674:0
- 3,363 shares0Common StockSEC:0001209191-08-000692:0
- 11,212 shares0Common StockSEC:0001209191-08-000668:0
- 6,777 shares0Common StockSEC:0001209191-08-000679:0
- 2,000,000 shares@ US$2.50Common StockSEC:0001041885-07-000078:0
15 of 15 declarations
About Alseres Pharmaceuticals Inc /DE
ALSERES PHARMACEUTICALS INC is a US-based pharmaceutical company focused on developing innovative treatments. It is listed on NASDAQ under the ticker ALSE.
